Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Titre(s) : Insights to neuroimmune biology [Texte électronique] / edited by Istvan Berczi
Édition : Second edition
Publication : Cambridge, MA : Elsevier, [2016]
Description matérielle : 1 online resource
Note(s) : Insights to Neuroimmune Biology, Second Edition discusses the systemic regulatory
network, coordination, organization, and interpretation of the rapidly accumulating
knowledge on the topic of neuroimmune biology, with an ultimate goal of helping readers
understand the function of higher organisms, including man, in their entire complexity.
This publication provides assessments and interpretations of accumulated experimental
evidence, enabling the scientific community to keep abreast of essential advancements
of existing knowledge as we search for greater understanding of the biology of higher
organisms.
Autre(s) auteur(s) : Berczi, Istvan. Auteur ou responsable intellectuel
Sujet(s) : Neuroimmunologie
Système immunitaire -- Physiopathologie
Identifiants, prix et caractéristiques : ISBN 9780128017708
Identifiant de la notice : ark:/12148/cb451096396
Notice n° :
FRBNF45109639
(notice reprise d'un réservoir extérieur)
Table des matières : Cover ; Title page; Copyright; Table of Contents ; List of Contributors; Foreword;
Preface; Part 1 -- Introduction: Neuroimmune Regulation in Health and Disease ; Chapter
1 -- Neuroimmune Regulation in Health and Disease; 1 -- Introduction; 1.1 -- Health;
2 -- Disease; 2.1 -- A Brief History; 2.2 -- HPA Axis and Disease; 2.2.1 -- New Observations
Showing that Stress may be Beneficial; 2.2.2 -- Early Life Programming by GCs; 2.2.3
-- Schizophrenia; 2.2.4 -- Alzheimer's Disease (AD); 2.2.5 -- Huntington's Disease
(HD); 2.2.6 -- Multiple Sclerosis (MS); 2.2.7 -- Anxiety and Depression
2.2.8 -- Major Depressive Disorder2.2.9 -- Various Other Forms of Depression; 2.2.10
-- Inflammation; 2.2.11 -- Various Other Conditions; 2.2.12 -- Agents that Influence
the HPA axis; 2.2.13 -- Regulatory Mechanisms of HPA Axis; 3 -- Discussion; 4 -- Conclusions;
References; Chapter 2 -- The Neuroimmune Supersystem; 1 -- Introduction; 2 -- The
neuroimmune supersystem; 3 -- Immunocompetence; 3.1 -- Adaptive Immunocompetence;
3.2 -- Innate or Natural Immunocompetence; 4 -- Growth signaling in the IS; 4.1 --
Signaling by GLH; 4.2 -- Antigen Presentation; 5 -- Immune neuroendocrine feedback
signals
6 -- Homeostasis, the immune-neuroendocrine circuitry6.1 -- Immunoregulation by the
HPA Axis; 7 -- Acute illness; 7.1 -- Neurogenic Inflammation; 7.2 -- The Acute Phase
Response (APR); 8 -- Healing; 9 -- Conclusions: the biological significance of NISS;
References; Part 2 -- Hypothalamic Immunoregulation ; Chapter 3 -- Multifactorial
Regulation of GLH Hormones; 1 -- Immunoregulation by the pituitary gland; 2 -- Immunoregulation
by growth and lactogenic hormones; 2.1 -- Immunoregulatory Pathways; 2.1.1 -- Thymus;
2.1.2 -- Receptors for GLH in Various Cells and Tissues; 2.1.3 -- Immune Reactions
2.1.4 -- Acute Febrile Illness (Acute phase response (APR))3 -- Dopamine in neuroimmune
biology; 3.1 -- Dopamine Receptors in Tissues and Cells; 3.2 -- Conserved Dopamine
Neurotrophic Factor; 3.3 -- BRC; 3.4 -- Neuropeptide; 3.5 -- Interleukin; 4 -- Immunoregulation
by dopamine; 5 -- Oxytocin and ghrelin in immunity; 5.1 -- Ghrelin (GRL) and Immunity;
6 -- Conclusions; References; Chapter 4 -- An Update on Neural Regulators of the Hypothalamic-Pituitary-Adrenal
Axis; 1 -- Corticotropin-releasing hormone; 1.1 -- Proopiomelanocortin; 2 -- Neuropeptide
regulators of the HPA axis; 2.1 -- Urocortin
2.2 -- Catecholamines2.3 -- Apelin; 2.4 -- Cholecystokinin; 2.5 -- Leptin; 2.6 --
Leukotriens; 2.7 -- Natriuretic Peptide; 2.8 -- Neuromedins; 2.9 -- Neuropeptides;
2.10 -- Nociceptin/Orpanin; 2.11 -- PACAP; 2.12 -- Opioid Peptides; 2.13 -- Orexin;
2.14 -- Relaxin; 2.15 -- Sauvagine and Urotensin; 2.16 -- SCP and SRP; 2.17 -- Vasotocin;
3 -- CRH and the CNS; 4 -- CRH-Receptors 1 and 2 (CHR1, 2) and UCN Receptors; 5 --
Hormonal immunoregulation and the HPA axis; 5.1 -- Immunoregulaton by the Pituitary
Gland; 5.2 -- Endotoxin Shock; 5.3 -- Immunoregulation by the Submandibular Salivary
Gland
5.4 -- Combination Immunotherapy of Cancer